Target Name: LOC105374187
NCBI ID: G105374187
Review Report on LOC105374187 Target / Biomarker Content of Review Report on LOC105374187 Target / Biomarker
LOC105374187
Other Name(s): uncharacterized LOC105374187 | Uncharacterized LOC105374187, transcript variant X2 | LOC105374187 variant X5 | LOC105374187 variant X1 | Uncharacterized LOC105374187, transcript variant X5 | LOC105374187 variant X2 | LOC105374187 variant X4 | Uncharacterized LOC105374187, transcript variant X1 | Uncharacterized LOC105374187, transcript variant X4

LOC105374187: A Potential Drug Target and Biomarker

LOC105374187 is a gene that has not yet been assigned a specific function, but it is known to encode a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. The protein produced by this gene has been shown to play a role in the development and progression of certain diseases, which has led to its potential as a drug target or biomarker.

The Protein and Its Functions

LOC105374187 is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells. These proteins are involved in many different processes in the body, including cell division, migration, and regulation of signaling pathways.

One of the functions of LOC105374187 is its role in the development and progression of certain diseases, such as cancer. Studies have shown that LOC105374187 is involved in the regulation of cell growth and that it can be overexpressed in cancer cells, leading to the development of a more aggressive and invasive form of cancer.

Another function of LOC105374187 is its role in the regulation of pain. Studies have shown that LOC105374187 is involved in the regulation of pain perception and that it can be used as a potential drug target for the treatment of pain.

Potential Drug Target

The potential drug target for LOC105374187 is its role in the regulation of cell growth and the development of certain diseases. Drugs that target LOC105374187 and inhibit its activity could potentially be used to treat a variety of diseases, including cancer and pain.

One approach to targeting LOC105374187 is to use small molecules, such as drugs that inhibit the activity of its downstream signaling pathways. These small molecules would be expected to have a wide range of effects on the cell, including the inhibition of cell growth and the inhibition of the formation of new blood vessels that can support the growth and progression of cancer cells.

Biomarker

LOC105374187 may also be used as a biomarker for the diagnosis and monitoring of certain diseases. For example, if LOC105374187 is overexpressed in a patient with cancer, the production of this protein could be used as a marker for the presence and extent of the cancer. Similarly, if LOC105374187 is expressed in a patient with pain, the production of this protein could be used as a marker for the severity and persistence of the pain.

Conclusion

LOC105374187 is a gene that has not yet been assigned a specific function, but it is known to encode a protein that is involved in the development and progression of certain diseases. The potential drug target for LOC105374187 is its role in the regulation of cell growth and the development of cancer and pain. Additionally, LOC105374187 may also be used as a biomarker for the diagnosis and monitoring of certain diseases. Further research is needed to fully understand the role of LOC105374187 in the body and to develop effective treatments for its potential drug targets.

Protein Name: Uncharacterized LOC105374187

The "LOC105374187 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105374187 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105374193 | LOC105374207 | LOC105374210 | LOC105374211 | LOC105374217 | LOC105374218 | LOC105374224 | LOC105374226 | LOC105374234 | LOC105374265 | LOC105374287 | LOC105374294 | LOC105374300 | LOC105374316 | LOC105374318 | LOC105374320 | LOC105374325 | LOC105374329 | LOC105374341 | LOC105374344 | LOC105374362 | LOC105374364 | LOC105374377 | LOC105374378 | LOC105374421 | LOC105374428 | LOC105374432 | LOC105374434 | LOC105374456 | LOC105374494 | LOC105374497 | LOC105374505 | LOC105374506 | LOC105374514 | LOC105374521 | LOC105374522 | LOC105374523 | LOC105374524 | LOC105374527 | LOC105374533 | LOC105374535 | LOC105374553 | LOC105374584 | LOC105374591 | LOC105374595 | LOC105374608 | LOC105374610 | LOC105374613 | LOC105374645 | LOC105374660 | LOC105374683 | LOC105374701 | LOC105374713 | LOC105374724 | LOC105374726 | LOC105374736 | LOC105374737 | LOC105374754 | LOC105374756 | LOC105374778 | LOC105374786 | LOC105374793 | LOC105374795 | LOC105374809 | LOC105374811 | LOC105374820 | LOC105374848 | LOC105374860 | LOC105374875 | LOC105374879 | LOC105374882 | LOC105374890 | LOC105374898 | LOC105374903 | LOC105374906 | LOC105374910 | LOC105374915 | LOC105374925 | LOC105374928 | LOC105374935 | LOC105374939 | LOC105374942 | LOC105374945 | LOC105374968 | LOC105374971 | LOC105374974 | LOC105374976 | LOC105374985 | LOC105374989 | LOC105375005 | LOC105375010 | LOC105375016 | LOC105375019 | LOC105375020 | LOC105375021 | LOC105375024 | LOC105375032 | LOC105375033 | LOC105375039 | LOC105375043